Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib in chemo-refractory metastatic gastric cancer
NCT00411151Phase 2Completed
- Sponsor
- Johannes Gutenberg University Mainz
- Start
- Dec 2006
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in gastric adenocarcinoma, Barrett's esophagus, sponsored by Johannes Gutenberg University Mainz. Started Dec 2006; status: completed.
02
Drugs
sunitinib
03
Conditions
gastric adenocarcinomaBarrett's esophagus
Beyond the preview
Go deeper on NCT00411151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00411151.